Related content

A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective

By Hommer A.   Wickstrøm J.   Friis M.M.   Steeds C.   Thygesen J.   Ferreras A.   Gouws P.   Buchholz P.  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1057-1063

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness analysis, welfare economics, and the societal perspective: a reply

By Liljas Bengt  

The European Journal of Health Economics, Vol. 11, Iss. 6, 2010-12 ,pp. : 597-598

Springer Publishing Company

Access to resources Recommend Favorite

Impact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective

By Boonen Steven  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2335-2341

Informa Healthcare

Access to resources Recommend Favorite

A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US*

By Charles Meaghan St.   Minshall Michael E.   Pandya Bhavik J.   Baran Robert W.   Tunis Sandra L.  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1343-1353

Informa Healthcare

Access to resources Recommend Favorite

A cost-effectiveness analysis of immunotherapy with SQ allergen extract for patients with seasonal allergic rhinoconjunctivitis in selected European countries

By Keiding Hans   Jørgensen Kasper P.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1113-1120

Informa Healthcare

Access to resources Recommend Favorite